Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma

Table 1 Clinical characteristics of patients in training and validation sets

Annotation: Lifelong non-smoker (less than 100 cigarettes smoked in lifetime) = 1; current smoker (includes daily smokers and non-daily smokers or occasional smokers) = 2; current reformed smoker for > 15 years (greater than 15 years) = 3; current reformed smoker for ≤ 15 years (less than or equal to 15 years) = 4; current reformed smoker, duration not specified = 5; smoking history not documented = 7

ISSN: 1477-7819